Company Intelligence

Recursion

AI and automation platform for drug discovery

In this profile

Quick Facts

Executive Summary

Recursion combines automated biology and AI to industrially scale drug discovery. Official materials describe a platform that maps biology and generates insights for therapeutic programs.Verified details are taken from Recursion’s official website.

Why It Matters

Recursion is a public TechBio reference for AI-enabled drug discovery with an official R&D platform footprint.

Products

Connected Reports

Connected Insights

Industries

Technologies

Introduction

Recursion combines automated biology and AI to industrially scale drug discovery. Official materials describe a platform that maps biology and generates insights for therapeutic programs.

Verified details are taken from Recursion’s official website.

What the company does

TechBio company using AI and automated experiments for drug discovery, documented on recursion.com.

Who it serves

Biopharma partners and internal pipelines for therapeutic discovery.

Company background

United States

Product and AI capabilities

TechBio company using AI and automated experiments for drug discovery, documented on recursion.com.

Key developments

Why it matters

Recursion is a public TechBio reference for AI-enabled drug discovery with an official R&D platform footprint.

Sector context

See Brel’s Healthcare sector hub for related profiles.

Sources and references

Official: https://www.recursion.com

Official resources

Sources and references

This article draws on publicly available company information, official websites, filings, interviews, announcements, and other cited sources. Information may change over time.

Company information is based on publicly available sources and is reviewed periodically. If you represent this company and would like to request a correction, contact Brel.

Explore Related Intelligence

The AI Brief

Weekly company intelligence in your inbox.

Subscribe